Similar articles

• The International Commission for Protection against Environmental Mutagens and Carcinogens (ICPEMC): the first seven years.

  Jansen JD. Jansen JD. Regul Toxicol Pharmacol. 1984 Jun;4(2):138-44. doi: 10.1016/0273-2300(84)90036-9. Regul Toxicol Pharmacol. 1984. PMID: 6739865
• International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Publication No. 12. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICPEMC Expert Group on Antimutagens and Desmutagens.

  Ramel C, Alekperov UK, Ames BN, Kada T, Wattenberg LW. Ramel C, et al. Mutat Res. 1986 Jul;168(1):47-65. doi: 10.1016/0165-1110(86)90021-7. Mutat Res. 1986. PMID: 3520303 Review. No abstract available.
• International Commission for Protection Against Environmental Mutagens and Carcinogens. Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9.

  Scott D, Galloway SM, Marshall RR, Ishidate M Jr, Brusick D, Ashby J, Myhr BC. Scott D, et al. Mutat Res. 1991 Mar;257(2):147-205. doi: 10.1016/0165-1110(91)90024-p. Mutat Res. 1991. PMID: 2005937 Review. No abstract available.
• International Commission for Protection Against Environmental Mutagens and Carcinogens. Report of ICPEMC Subcommittee 7/1. The possible involvement of somatic mutations in the development of atherosclerotic plaques.

  [No authors listed] [No authors listed] Atherosclerosis. 1991 Aug;89(2-3):255-61. Atherosclerosis. 1991. PMID: 1793453 No abstract available.
• International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 10. Review of the evidence for the presence or absence of thresholds in the induction of genetic effects by genotoxic chemicals.

  Ehling UH, Averbeck D, Cerutti PA, Friedman J, Greim H, Kolbye AC Jr, Mendelsohn ML. Ehling UH, et al. Mutat Res. 1983 Dec;123(3):281-341. doi: 10.1016/0165-1110(83)90026-x. Mutat Res. 1983. PMID: 6646151 No abstract available.